2022
DOI: 10.3390/a15010021
|View full text |Cite
|
Sign up to set email alerts
|

Graph Based Feature Selection for Reduction of Dimensionality in Next-Generation RNA Sequencing Datasets

Abstract: Analysis of high-dimensional data, with more features () than observations () (), places significant demand in cost and memory computational usage attributes. Feature selection can be used to reduce the dimensionality of the data. We used a graph-based approach, principal component analysis (PCA) and recursive feature elimination to select features for classification from RNAseq datasets from two lung cancer datasets. The selected features were discretized for association rule mining where support and lift wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…To determine the same, different graph approaches have been proposed for feature selection [25][26][27][28][29][30][31][32][33][34][35][36][37]. Das et al [30] used Feature Association Map to present a graph-based hybrid feature selection method.…”
Section: Introductionmentioning
confidence: 99%
“…To determine the same, different graph approaches have been proposed for feature selection [25][26][27][28][29][30][31][32][33][34][35][36][37]. Das et al [30] used Feature Association Map to present a graph-based hybrid feature selection method.…”
Section: Introductionmentioning
confidence: 99%
“…The hybrid method gave better results than the individual algorithms. Gakii et al [32] proposed comparison methods using three algorithms for feature selection included in the PCA, RFE and graph-based feature selection. The results proved that the graph-based feature selection enhanced the performance of sequential minimal optimization and multilayer perceptron classifiers.…”
Section: Introductionmentioning
confidence: 99%
“…For example in domains like the various omics (e.g. genomics), biomedical imaging, and biomedical signal processing, biological molecule sequencing, we can see various applications of deep learning, such as gene expression regulation, protein structure prediction, cancer diagnosis and prognosis, drug discovery, and medical image analysis RNNs ( [72][73][74][75][76]. An example is visible in the synergy between AI and the CRISPR technologies applied to vaccine design, therapeutic treatment improvement and RNA guide activities [74,75,77].…”
Section: Ai In Bioinformaticsmentioning
confidence: 99%